Sawtooth Solutions, LLC Syros Pharmaceuticals, Inc. Transaction History

Sawtooth Solutions, LLC

  • $3.64 Billion
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
BUY
$0.69 - $1.21 $12,648 - $22,180
18,331 Added 76.52%
42,286 $41,000
Q1 2022

May 20, 2022
BUY
$1.02 - $3.8 $24,434 - $91,029
23,955 New
23,955 $29,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email